Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates
Stephanie E. Barrett(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven L. Colletti(Merck & Co., Inc., Rahway, NJ, USA (United States)), Eric Kemp, Jun Hyuk Heo(Korea Advanced Nano Fab Center), Nicole T. Pudvah(Merck & Co., Inc., Rahway, NJ, USA (United States)), Conrad E. Raab(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marc Abrams(Dicerna Pharmaceuticals (United States)), Melissa Stern(Merck & Co., Inc., Rahway, NJ, USA (United States)), Haihong Fan(United States Military Academy), Eric D. Soli(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marissa Vavrek(United States Military Academy), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Robert A. Kowtoniuk(United States Military Academy), Michael Lyman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marina Busuek, Steven J. Staskiewicz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sheri Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mihir Patel(United States Military Academy), Erin N. Guidry(Merck & Co., Inc., Rahway, NJ, USA (United States)), Stephanie Young(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bonnie J. Howell(Johns Hopkins University), Eileen S. Walsh(Janssen (Switzerland)), R. M. Garbaccio(United States Military Academy), Quang Truong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rubina Parmar(Alnylam Pharmaceuticals (United States)), Sean Riley(United States Military Academy), Jacob H. Waldman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carol Bason(Merck & Co., Inc., Rahway, NJ, USA (United States)), Brian Carr, Andrew H. Latham(United States Military Academy), Rob S. Burke(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sergei Pechenov(United States Military Academy), Jonathan Williams(University of Liverpool), Tao Pei(Merck & Co., Inc., Rahway, NJ, USA (United States)), Louis S. Crocker, Edward J. Carlini(Merck & Co., Inc., Rahway, NJ, USA (United States)), Anthony Leone
Cited by 31
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409